Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
Pellentesque dignissim sapien semper
$78.00Add to cartCras luctus ultricies ex luctus malesuada. Fusce imperdiet interdum consectetur. Pellentesque dignissim sapien semper consequat sollicitudin. Phasellus iaculis libero ac placerat aliquam. Etiam a velit eu diam consequat vestibulum. Ut a malesuada nulla. Vivamus quis maximus nisi, vel molestie sapien. Nunc pharetra finibus elit sed consectetur.
-
Quick View
The Ultimate Guide to Choosing the Best Insulation for Your Ceiling
$123.00Original price was: $123.00.$122.00Current price is: $122.00.Add to cartWhen it comes to insulating your home, the ceiling plays a crucial role in maintaining a comfortable indoor environment. The right insulation can significantly improve energy efficiency, reduce utility bills, and enhance overall comfort. In this comprehensive guide, we will explore the various types of insulation available for ceilings and help you make an informed …
The Ultimate Guide to Choosing the Best Insulation for Your CeilingRead More
-
Quick View
Quisque mi est, blandit sed maximus
$63.00Original price was: $63.00.$57.00Current price is: $57.00.Add to cartDuis feugiat sapien et augue dignissim porta. Nullam magna velit, laoreet porta vestibulum nec, auctor sed dui. Integer ac sodales enim. Quisque magna est, mollis euismod nibh in, elementum congue orci. Cras viverra, elit vitae iaculis efficitur, turpis urna sodales eros, vel finibus lacus elit sit amet dolor. Praesent at erat in purus pretium laoreet.
-
Quick View
Aenean non pellentesque mauris
$68.00Original price was: $68.00.$55.00Current price is: $55.00.Add to cartNullam porttitor pharetra ullamcorper. Praesent varius erat vitae nibh laoreet cursus. Donec suscipit gravida viverra. Suspendisse consectetur ipsum augue, a varius enim tempus a. Phasellus id nibh arcu. Curabitur rutrum vehicula mi id congue. Phasellus vitae leo sodales, pretium turpis non, efficitur eros. Donec fermentum at nisi suscipit vulputate.






Reviews
There are no reviews yet.